Barnard Rosanna C, Davies Nicholas G, Jit Mark, Edmunds W John
Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
medRxiv. 2022 May 20:2021.11.22.21266584. doi: 10.1101/2021.11.22.21266584.
England has experienced a heavy burden of COVID-19, with multiple waves of SARS-CoV-2 transmission since early 2020 and high infection levels following the emergence and spread of Omicron variants since late 2021. In response to rising Omicron cases, booster vaccinations were accelerated and offered to all adults in England. Using a model fitted to more than 2 years of epidemiological data, we project potential dynamics of SARS-CoV-2 infections, hospital admissions and deaths in England to December 2022. We consider key uncertainties including future behavioural change and waning immunity, and assess the effectiveness of booster vaccinations in mitigating SARS-CoV-2 disease burden between October 2021 and December 2022. If no new variants emerge, SARS-CoV-2 transmission is expected to decline, with low levels remaining in the coming months. The extent to which projected SARS-CoV-2 transmission resurges later in 2022 depends largely on assumptions around waning immunity and to some extent, behaviour and seasonality.
自2020年初以来,英国经历了沉重的新冠负担,自2021年末奥密克戎变异株出现并传播后,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已出现多轮传播,感染水平居高不下。为应对奥密克戎病例的增加,英国加快了加强针接种,并向所有成年人提供了加强针。利用一个拟合了两年多流行病学数据的模型,我们预测了到2022年12月英国SARS-CoV-2感染、住院和死亡的潜在动态。我们考虑了包括未来行为变化和免疫力下降在内的关键不确定性因素,并评估了加强针接种在减轻2021年10月至2022年12月期间SARS-CoV-2疾病负担方面的有效性。如果没有新的变异株出现,预计SARS-CoV-2传播将会下降,未来几个月感染水平将维持在较低水平。预计2022年晚些时候SARS-CoV-2传播再次激增的程度,在很大程度上取决于有关免疫力下降的假设,在一定程度上还取决于行为和季节性因素。